the biases of using bone marrow biopsies for multiple myeloma
Published 6 years ago • 1.4K plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
0:59
defining the origins of multiple myeloma
-
7:38
bone marrow biopsy in patients with plasma cell disorders
-
1:54
multiple myeloma: the bone marrow niche
-
0:42
factors to consider when selecting patients with multiple myeloma for treatment with bispecifics
-
1:36
multivariate model to predict the need for bone marrow sampling in patients with mgus
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
6:23
how long will i live with multiple myeloma, and is there a cure? #myeloma
-
1:33:50
clonality in acquired bone marrow failure, pnh, vexas
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
1:36
the use of outpatient cilta-cel in the treatment of multiple myeloma
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
3:48
trials of interest in newly diagnosed myeloma presented at ims 2024
-
3:00
current & emerging biomarkers in multiple myeloma
-
2:01
ctcs as a biomarker of tumor burden in multiple myeloma
-
2:42
the value of circulating tumor cells for the staging of patients with ndmm
-
1:32
the use of belantamab mafodotin in triplet combinations for multiple myeloma
-
1:33
circulating tumor cells in multiple myeloma
-
4:06
the impact of rbps in the development of hematological malignancies and bone marrow failure
-
2:17
mrd: a promising biomarker in multiple myeloma
-
1:02
novel agents in multiple myeloma: considering toxicity and side effects
-
2:11
unmet needs in bone marrow failure syndromes & myeloid malignancies: characterization & novel agents